We are live on ! Find out more
CLLS

Cellectis

86 hedge funds and large institutions have $319M invested in Cellectis in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 9

131% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 13

44% more capital invested

Capital invested by funds: $222M → $319M (+$96.9M)

25% more funds holding

Funds holding: 6986 (+17)

7.15% more ownership

Funds ownership: 19.63%26.78% (+7.2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

58% less call options, than puts

Call options by funds: $1.38M | Put options by funds: $3.33M

Holders
86
Holders Change
+17
Holders Change %
+24.64%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
30
Reduced
13
Closed
9
Calls
$1.38M
Puts
$3.33M
Net Calls
-$1.95M
Net Calls Change
-$2.2M

CLLS Hedge Fund Activity: Q2 2018 in Review

86 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2018, worth a combined $319M — up 44% from $222M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CLLS positions and 9 closed out — a net gain of 18 holders — while 30 added to existing stakes and 13 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $26.1M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $9.45M sold.

  • 86 institutional investors held Cellectis (CLLS) as of Q2 2018, up from 69 in Q1 2018.
  • Funds reported $319M of Cellectis stock for Q2 2018, up 44% quarter-over-quarter.
  • 27 funds opened new Cellectis positions in Q2 2018 and 9 closed out, a net change of +18 holders.
  • The largest Cellectis buyer in Q2 2018 was Capital World Investors, an estimated $26.1M added.
  • The largest Cellectis seller in Q2 2018 was Perceptive Advisors, an estimated $9.45M sold.

Based on aggregated 13F filings for Q2 2018.